magnesium sulfate has been researched along with Ductus Arteriosus, Patent in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Blanco, CE; Cogolludo, AL; Dias-Guichot, R; Mohammed, R; van der Sterren, S; Villamor, E | 1 |
| Momma, K; Nakanishi, T; Toyoshima, K | 1 |
| Enomoto, M; Hayashi, S; Katayama, Y; Lee, YK; Minami, H; Takano, T | 1 |
| Basu, SK; Bhutada, A; Chickajajur, V; Lopez, V; Pagala, M; Rastogi, S | 1 |
| Bancalari, E; Claure, N; del moral, T; Gonzalez-Quintero, VH; Vanbuskirk, S | 1 |
| Lin, SC; Teng, RJ; Wang, JK | 1 |
| Bental, Y; Davkin, O; Lusky, A; Reichman, B; Rotschild, A; Solovechick, M; Waisman, D; Weintraub, Z | 1 |
7 other study(ies) available for magnesium sulfate and Ductus Arteriosus, Patent
| Article | Year |
|---|---|
Vasoactivity of magnesium sulfate in chicken ductus arteriosus.
Topics: Animals; Calcium; Chick Embryo; Dinoprostone; Ductus Arteriosus; Ductus Arteriosus, Patent; Magnesium Sulfate; Nitric Oxide; Vasodilation | 2020 |
Fetal reversed constrictive effect of indomethacin and postnatal delayed closure of the ductus arteriosus following administration of transplacental magnesium sulfate in rats.
Topics: Animals; Animals, Newborn; Anti-Inflammatory Agents, Non-Steroidal; Disease Models, Animal; Drug Antagonism; Ductus Arteriosus; Ductus Arteriosus, Patent; Embryo, Mammalian; Female; Indomethacin; Magnesium Sulfate; Male; Maternal-Fetal Exchange; Muscle Contraction; Muscle, Smooth, Vascular; Pregnancy; Rats; Rats, Wistar; Tocolytic Agents | 2009 |
Antenatal magnesium sulfate and the postnatal response of the ductus arteriosus to indomethacin in extremely preterm neonates.
Topics: Drug Administration Schedule; Ductus Arteriosus; Ductus Arteriosus, Patent; Female; Gestational Age; Humans; Incidence; Indomethacin; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Logistic Models; Magnesium Sulfate; Male; Pregnancy; Prenatal Care; Retrospective Studies; Tocolytic Agents; Treatment Outcome | 2011 |
Immediate clinical outcomes in preterm neonates receiving antenatal magnesium for neuroprotection.
Topics: Cerebral Palsy; Ductus Arteriosus, Patent; Female; Gestational Age; Humans; Infant Mortality; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Magnesium; Magnesium Sulfate; Neuroprotective Agents; Pregnancy; Retinopathy of Prematurity; Retrospective Studies; Treatment Outcome | 2011 |
Antenatal exposure to magnesium sulfate and the incidence of patent ductus arteriosus in extremely low birth weight infants.
Topics: Anticonvulsants; Dose-Response Relationship, Drug; Ductus Arteriosus, Patent; Female; Humans; Infant, Newborn; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Magnesium Sulfate; Male; Retrospective Studies; Tocolytic Agents | 2007 |
Management of severe pulmonary hypertension in an infant with obstructed total anomalous pulmonary venous return using magnesium sulfate.
Topics: Alprostadil; Ductus Arteriosus, Patent; Heart Defects, Congenital; Humans; Hypertension, Pulmonary; Hypoxia; Infant; Magnesium Sulfate; Male; Oxygen; Pulmonary Atresia; Pulmonary Circulation; Pulmonary Veins; Respiration, Artificial; Vasodilator Agents | 1996 |
Effect of maternal tocolysis on the incidence of severe periventricular/intraventricular haemorrhage in very low birthweight infants.
Topics: Anti-Inflammatory Agents; Apgar Score; Ductus Arteriosus, Patent; Female; Gestational Age; Humans; Indomethacin; Infant, Newborn; Infant, Very Low Birth Weight; Intracranial Hemorrhages; Logistic Models; Magnesium Sulfate; Multivariate Analysis; Pneumothorax; Pregnancy; Prenatal Exposure Delayed Effects; Respiration, Artificial; Respiratory Distress Syndrome, Newborn; Risk Factors; Ritodrine; Steroids; Tocolytic Agents | 2001 |